載入...
BCX4430 – A broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease
The adenosine nucleoside analog BCX4430 is a direct-acting antiviral drug under investigation for the treatment of serious and life-threatening infections from highly pathogenic viruses, such as the Ebola virus. Cellular kinases phosphorylate BCX4430 to a triphosphate that mimics ATP; viral RNA poly...
Na minha lista:
| 發表在: | J Infect Public Health |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
King Saud Bin Abdulaziz University for Health Sciences. Production and hosting by Elsevier Limited.
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4937725/ https://ncbi.nlm.nih.gov/pubmed/27095300 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jiph.2016.04.002 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|